Siemens Healthineers reports buyback. Siemens Healthineers stock gains 1.60 percent
Published on 10/06/2026 at 11:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Siemens Healthineers (ISIN DE000SHL1006) was trading at EUR 38.05 at Lang & Schwarz on October 6, 2026 at 11:02 a.m. CEST, up 1.60 percent from the prior close of EUR 37.45. The latest company disclosure shows continued share repurchases, while Deutsche Bank Research has kept a cautious Hold view ahead of the next results.
Buyback reaches 3.4 million shares
According to Deutsche Boerse on October 5, 2026, Siemens Healthineers bought back 49,987 shares between September 28 and October 4. The disclosure puts cumulative purchases since June 1 at 3,424,346 shares, with the transactions executed on Xetra.
The latest tranche included 10,000 shares on September 28 at a weighted average EUR 38.9163, 10,000 shares on September 29 at EUR 38.8078, and 9,987 shares on September 30 at EUR 38.1512. The buyback therefore continued across the same period in which the stock moved below its recent trading levels.
Deutsche Bank keeps target at EUR 39
Finanzen reported on October 5, 2026 that Deutsche Bank Research retained its Hold rating and EUR 39.00 price target before Siemens Healthineers reports its fourth fiscal quarter. The bank forecast 6.00 percent organic revenue growth but described profitability as weak, making the next outlook for fiscal 2027 the central test.
The latest reported third quarter of fiscal 2026 provides a mixed benchmark. VCBeat reported revenue of EUR 5.764 billion, up 1.80 percent year over year, while adjusted EBIT rose 15.60 percent to EUR 1.101 billion and net profit increased 21.70 percent to EUR 676.0 million in the quarter ended June 30, 2026.
Stock remains 23.46 percent below high
At EUR 38.05, the Lang & Schwarz price stood EUR 11.66 below the 52-week high of EUR 49.71 and EUR 5.24 above the 52-week low of EUR 32.81 on October 6, 2026. That distance leaves the valuation debate tied to execution: improving adjusted EBIT has not yet removed concern over diagnostics performance and the fiscal 2027 outlook.
The company's investor-relations calendar lists November 5, 2026 for fourth-quarter figures and the analyst call, followed by a November 6, 2026 roadshow. The date and event are stated on the Siemens Healthineers investor-relations page.
Price holds above the yearly low
Siemens Healthineers was trading at EUR 38.05 at Lang & Schwarz on October 6, 2026 at 11:02 a.m. CEST, plus 1.60 percent versus the prior close of EUR 37.45. The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.
Siemens Healthineers stock facts
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- WKN: SHL100
- Ticker: SHL
- Primary exchange: Xetra
- Price Lang & Schwarz as of October 6, 2026, 11:02 a.m. CEST: EUR 38.05
- Change versus prior close: plus 1.60 percent
- Prior close Lang & Schwarz September 30, 2026: EUR 37.45
- Market capitalization: EUR 42.6 billion as of October 6, 2026
- 52-week range: EUR 32.81-49.71 as of October 6, 2026
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: November 5, 2026
